SCHEMBL24330665

SCHEMBL24330665

Cc1cccc(C)c1-c1cc(Cl)nc(NS(=O)(=O)c2cccc(CBr)c2)n1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.40
▸ PGR P06401 2/20 0.38
▸ PKM P14618 4/20 0.38
▸ GAA P10253 4/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ ADRA2B P18089 1/20 0.37
▸ MAPT P10636 3/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ KDM1A O60341 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ EDNRB P24530 1/20 0.35
▸ EDNRA P25101 1/20 0.35
▸ MAOA P21397 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29703022 1.00 TSHR (0.40) TSHRPGRPKMGAASMN1; SMN2
SCHEMBL24330690 0.89 PTGES2 (0.41) TSHRPGRPKMGAASMN1; SMN2
SCHEMBL26822143 0.84 CYTH2 (0.45) TSHRPKMGAASMN1; SMN2ADRA2B
SCHEMBL26838876 0.82 TSHR (0.40) TSHRPGRPKMGAASMN1; SMN2
SCHEMBL24299125 0.81 HDAC3 (0.42) TSHRPKMSMN1; SMN2HTTKDM4E
SCHEMBL22502033 0.81 KDM4E (0.50) TSHRKDM4EKMT2AALDH1A1
SCHEMBL29570965 0.81 PKM (0.41) TSHRPKMGAASMN1; SMN2MAPT
SCHEMBL24325422 0.81 PKM (0.41) TSHRPKMGAASMN1; SMN2MAPT
SCHEMBL29447227 0.81 KDM4E (0.50) TSHRKDM4EKMT2AALDH1A1
SCHEMBL29457779 0.81 LMNA (0.55) MAPTKDM4EKMT2AKDM1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076626-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback